Sunrest Lifescience Confirms Corporate Governance Exemption for Q2 FY27
Sunrest Lifescience Ltd · Others (Uncategorized) · 20 Oct 2026, 1:41 am
Sunrest Lifescience Confirms Corporate Governance Exemption for Q2 FY27 Sunrest Lifescience Limited confirmed the non-applicability of Regulation 27(2) corporate governance reporting under SEBI LODR Regulations for the quarter ended 30th Sep'26. The company qualifies for exemption under Regulation 15 as an NSE Emerge SME-listed entity. Additionally, practicing company secretary certification confirms that paid-up equity share capital remained at ₹4.29 crore across FY24–FY26 (below the ₹10.00 crore threshold) and net worth stood at ₹19.27 crore in FY26 (below the ₹25.00 crore limit), exempting it from mandatory filings.
Original exchange filing (PDF)
More announcements from Sunrest Lifescience Ltd
- Sunrest Lifescience Limited has submitted to the Exchange, the standalone and Consolidated unaudited financial results for the half year ended September 30, 2026. · 15 Nov 2026
- SUNREST LIFESCIENCE LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 14 Nov 2026
- To consider and approve Unaudited Standalone and Consolidated financial results for the Half Year ended September 30, 2026 and other business matters · 14 Nov 2026
- SDD Compliance Certificate for the Quarter ended on 30th September, 2026 · 09 Oct 2026
- Sunrest Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on September 11, 2026 in relation to Dissolving the Right Issue due to non receipt of minimum subscription and other other matters · 11 Sept 2026
- Sunrest Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 07, 2026. Further, the company has informed the Exchange regarding voting results. · 07 Sept 2026
- Sunrest Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 07, 2026 · 07 Sept 2026
- Sunrest Lifescience Limited has informed the Exchange that Board of Directors at its meeting held on September 02, 2026, has decided to extend the issue of equity shares on rights basis in the ratio of 1 : 1, i.e 1 Equity Shares for every 1 Equity Shares held. Issue Price is Rs. 35 per share. · 02 Sept 2026
